Skip to main content

PMatch

Category: AI in Healthcare

Korean healthcare startup developing Pilltalk, an AI medication safety solution that analyzes drug interactions and polypharmacy risks for elderly care and insurance workflows. PMatch was founded in 2021. The company is led by Hyoungki Lee (이형기, Howard Lee). Based in Seoul, South Korea. Team size: 11-50. Latest round: Undisclosed. Key investors include Samsung Fire & Marine Insurance–Infobank Value-Up Venture Fund No. 2, SNAAC (Seoul National University Accelerator).

Founded
2021
Headquarters
Seoul, South Korea
Team size
11-50

Value proposition

AI-powered medication safety platform that detects ingredient overlap and hazardous drug combinations, generating a medication safety report with a safety score and risk grade to prevent polypharmacy harm in elderly care.

Products and solutions

Pilltalk (consumer AI medication safety app, launched Jan 2026, free on Google Play/App Store), Pilltalk biz cares (B2B version for care settings with web dashboard for facility administrators, launched April 2025), Geonjeonji (건전지, earlier health functional food information app).

Unique value

Quantifies medication safety via AI (safety score + risk grade) and establishes a standard usable across care, healthcare, and insurance underwriting — backed by clinical pharmacology expertise from Seoul National University Hospital.

Target customer

Elderly patients on multiple medications, welfare workers and pharmacists in care facilities, municipal governments, home-based care agencies, and insurance underwriters.

Industries served

Healthcare, Elderly care / community integrated care, Insurance (underwriting), Local government public health programs.

Technology advantage

AI model for polypharmacy management in the elderly; detects ingredient overlap and hazardous drug combinations; produces quantified medication safety reports (safety score + risk grade); clinical pharmacology foundation from Seoul National University Hospital.

How they differentiate

Combines clinical pharmacology expertise (SNU Hospital) with AI to quantify medication safety into a score/grade, targeting both consumer (Pilltalk app) and B2B care/insurance workflows — positioning to establish a standard for medication safety management in insurance underwriting.

Main competitors

YMYD (AI drug risk solutions, also backed by Samsung Fire), WeAid (dental insurance claim automation), other Korean digital health / medication management startups

Key partnerships

Samsung Fire & Marine Insurance–Infobank Value-Up Venture Fund No. 2 (investor), Seoul Metropolitan Government "Companion to the Vulnerable" grant program, Gwanak District home pharmacy initiative, SNAAC (Seoul National University Accelerator).

Notable customers

Multiple municipal governments and home-based care agencies in greater Seoul and provincial regions (paid contracts), Seoul's Gwanak District home pharmacy initiative.

Major milestones

Founded 2021 by Prof. Hyoungki Lee, Pilltalk officially launched Jan 2025, Pilltalk biz cares launched April 2025, Gwanak District home pharmacy initiative recognized Feb 2025 as AI smart home pharmacy innovation case, raised investment from Samsung Fire & Marine Insurance–Infobank Value-Up Venture Fund No. 2 (Aug 2026).

Market positioning

Early-stage Korean healthcare startup in the AI medication safety / polypharmacy management niche, gaining traction with municipal governments and home-based care agencies, and expanding into insurance underwriting.

Geographic focus

South Korea

About Hyoungki Lee (이형기, Howard Lee)

Professor at Seoul National University Dept. of Molecular Medicine & Biopharmaceutical Sciences and Clinical Pharmacology at Seoul National University Hospital; ex-Associate Professor at UCSF School of Pharmacy; ex-Assistant Professor at University of Pittsburgh School of Medicine; ex-Director of Global Strategy Office, SNU Hospital Clinical Trial Center. MD/PhD (Preventive Medicine, Epidemiology) from Seoul National University College of Medicine.

Latest news about PMatch

More AI in Healthcare companies

Official website: